96 related articles for article (PubMed ID: 23980689)
1. Human-β-defensins-1-3 and analogs do not require proton motive force for antibacterial activity against Escherichia coli.
Krishnakumari V; Packiyanathan KK; Nagaraj R
FEMS Microbiol Lett; 2013 Nov; 348(1):52-7. PubMed ID: 23980689
[TBL] [Abstract][Full Text] [Related]
2. Experimental Evolution of Escherichia coli K-12 in the Presence of Proton Motive Force (PMF) Uncoupler Carbonyl Cyanide
Griffith JM; Basting PJ; Bischof KM; Wrona EP; Kunka KS; Tancredi AC; Moore JP; Hyman MRL; Slonczewski JL
Appl Environ Microbiol; 2019 Mar; 85(5):. PubMed ID: 30578262
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial activities of synthetic peptides corresponding to the carboxy-terminal region of human beta-defensins 1-3.
Krishnakumari V; Singh S; Nagaraj R
Peptides; 2006 Nov; 27(11):2607-13. PubMed ID: 16860904
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial activity of human neutrophil defensin HNP-1 analogs without cysteines.
Varkey J; Nagaraj R
Antimicrob Agents Chemother; 2005 Nov; 49(11):4561-6. PubMed ID: 16251296
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of decreased susceptibility to beta-defensins by Treponema denticola.
Brissette CA; Lukehart SA
Infect Immun; 2007 May; 75(5):2307-15. PubMed ID: 17325047
[TBL] [Abstract][Full Text] [Related]
6. Effects of increasing hydrophobicity by N-terminal myristoylation on the antibacterial and hemolytic activities of the C-terminal cationic segments of human-β-defensins 1-3.
Krishnakumari V; Guru A; Adicherla H; Nagaraj R
Chem Biol Drug Des; 2018 Aug; 92(2):1504-1513. PubMed ID: 29682907
[TBL] [Abstract][Full Text] [Related]
7. N-terminus three residues deletion mutant of human beta-defensin 3 with remarkably enhanced salt-resistance.
Li T; Guo F; Wang Q; Fang H; Li Z; Wang D; Wang H
PLoS One; 2015; 10(2):e0117913. PubMed ID: 25706284
[TBL] [Abstract][Full Text] [Related]
8. Elevated Membrane Potential as a Tetracycline Resistance Mechanism in
Kuang SF; Xiang J; Zeng YY; Peng XX; Li H
ACS Infect Dis; 2024 Jun; 10(6):2196-2211. PubMed ID: 38836553
[TBL] [Abstract][Full Text] [Related]
9. Active Efflux Leads to Heterogeneous Dissipation of Proton Motive Force by Protonophores in Bacteria.
Le D; Krasnopeeva E; Sinjab F; Pilizota T; Kim M
mBio; 2021 Aug; 12(4):e0067621. PubMed ID: 34253054
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activity of human β-defensins against lactic acid bacteria.
Wang XF; Tian F; Cao RM; Li J; Wu SM; Guo XK; Chen TX
Nat Prod Res; 2015; 29(22):2164-6. PubMed ID: 25560646
[TBL] [Abstract][Full Text] [Related]
11. Osmotic adaptation of Escherichia coli with a negligible proton motive force in the presence of carbonyl cyanide m-chlorophenylhydrazone.
Ohyama T; Mugikura S; Nishikawa M; Igarashi K; Kobayashi H
J Bacteriol; 1992 May; 174(9):2922-8. PubMed ID: 1314804
[TBL] [Abstract][Full Text] [Related]
12. Effect of ions on antibacterial activity of human beta defensin 2.
Tomita T; Hitomi S; Nagase T; Matsui H; Matsuse T; Kimura S; Ouchi Y
Microbiol Immunol; 2000; 44(9):749-54. PubMed ID: 11092238
[TBL] [Abstract][Full Text] [Related]
13. Interaction of antibacterial peptides spanning the carboxy-terminal region of human beta-defensins 1-3 with phospholipids at the air-water interface and inner membrane of E. coli.
Krishnakumari V; Nagaraj R
Peptides; 2008 Jan; 29(1):7-14. PubMed ID: 18063441
[TBL] [Abstract][Full Text] [Related]
14. Proton-motive force stimulates the proteolytic activity of FtsH, a membrane-bound ATP-dependent protease in Escherichia coli.
Akiyama Y
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8066-71. PubMed ID: 12034886
[TBL] [Abstract][Full Text] [Related]
15. High-level expression and purification of a recombinant hBD-1 fused to LMM protein in Escherichia coli.
Cipáková I; Hostinová E; Gasperík J; Velebný V
Protein Expr Purif; 2004 Sep; 37(1):207-12. PubMed ID: 15294300
[TBL] [Abstract][Full Text] [Related]
16. Detection of a chloramphenicol efflux system in Escherichia coli isolated from poultry carcass.
Moreira MA; Oliveira JA; Teixeira LM; Moraes CA
Vet Microbiol; 2005 Aug; 109(1-2):75-81. PubMed ID: 15963664
[TBL] [Abstract][Full Text] [Related]
17. Effect of selectively introducing arginine and D-amino acids on the antimicrobial activity and salt sensitivity in analogs of human beta-defensins.
Olli S; Rangaraj N; Nagaraj R
PLoS One; 2013; 8(9):e77031. PubMed ID: 24086767
[TBL] [Abstract][Full Text] [Related]
18. Human beta-defensin-1: an antimicrobial peptide of urogenital tissues.
Valore EV; Park CH; Quayle AJ; Wiles KR; McCray PB; Ganz T
J Clin Invest; 1998 Apr; 101(8):1633-42. PubMed ID: 9541493
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of bactericidal activity of microcin L in Escherichia coli and Salmonella enterica.
Morin N; Lanneluc I; Connil N; Cottenceau M; Pons AM; Sablé S
Antimicrob Agents Chemother; 2011 Mar; 55(3):997-1007. PubMed ID: 21189348
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial peptides in bronchoalveolar lavage fluid.
Schnapp D; Harris A
Am J Respir Cell Mol Biol; 1998 Sep; 19(3):352-6. PubMed ID: 9730862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
